Mode
Text Size
Log in / Sign up
N/A Completed N=125 Randomized Double-blind Treatment

Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans

Source: ClinicalTrials.gov NCT02027558 ↗
Enrolled (actual)
125
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcomePrimary: Sleep Quality — 6.25; 9.87 score on a scale — p=<.001

Summary

The purpose of this study is to determine whether a novel intervention combining cognitive behavioral therapy for insomnia plus a positive airway pressure (PAP) behavioral adherence program provided by allied health personnel for older Veterans with obstructive sleep apnea and comorbid insomnia improves nighttime sleep and PAP adherence.

Outcome Measures

OutcomeResultp-value
PRIMARY
Sleep Quality
6.25; 9.87 <.001 sig
PRIMARY
Sleep Onset Latency From Sleep Diary
22.80; 35.77 0.013 sig
PRIMARY
Wake After Sleep Onset From Sleep Diary
20.42; 40.67 0.019 sig
PRIMARY
Sleep Efficiency From Sleep Diary
86.24; 75.69 0.001 sig
PRIMARY
Sleep Efficiency From Wrist Actigraphy
81.70; 78.51 0.001 sig
PRIMARY
PAP Adherence
38.58; 21.16 0.0007 sig

Eligibility Criteria

Inclusion Criteria

  • Meets diagnostic criteria for insomnia
  • Diagnosis of obstructive sleep apnea (AHI > or = 15) and prescription of PAP therapy
  • Age > or =50
  • Community-dwelling
  • Live within a 30-mile radius of VA GLAHS
  • Have transportation to VA GLAHS to attend the intervention/control programs

Exclusion Criteria

  • Significant cognitive impairment (MMSE < 24)
  • History of mania, major psychopathology or a psychiatric hospitalization in prior two years
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02027558). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search